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Long Term Results of ST-Segment Elevation Myocardial 
Infarction versus Non-ST-Segment Elevation Myocardial 
Infarction after Off-Pump Coronary Artery Bypass Grafting: 
Propensity Score Matching Analysis
There is no consensus as to which acute myocardial infarction subtype poses a greater risk 
after coronary artery bypass grafting (CABG). We compared the early and the long term 
results of off-pump coronary artery bypass grafting (OPCAB) between patients with STEMI 
(group I, n = 83), and NSTEMI (group II, n = 237). Group I had higher EuroSCORE, 
prevalence of emergency surgery, preoperative intra-aortic balloon pump use, preoperative 
emergency percutaneous transluminal coronary angioplasty, and preoperative thrombolytic 
use than group II. There were no significant differences in 30-day mortality and major 
adverse cardiac and cerebrovascular event (MACCE) between groups. Overall 8-yr survival 
was 93% and 87% in groups I and II, respectively. Freedom from MACCE after 8 yr was 
92% and 93% in groups I and II, respectively. After propensity score matching analysis, 
there were no significant differences in preoperative parameters, postoperative in-hospital 
outcomes, and long-term clinical outcomes. Surgical results of OPCAB in patients with 
acute myocardial infarction show good results in terms of long-term survival and freedom 
from MACCE, with no significant differences in clinical outcomes between STEMI and 
NSTEMI groups.
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Acute myocardial infarction (AMI) is classified into two subtypes: 
ST-segment elevation myocardial infarction (STEMI) and non-
ST-segment elevation myocardial infarction (NSTEMI) (1). The 
primary cause of culprit artery in NSTEMI is a non-occlusive 
thrombus exposed to the lumen of an artery, whereas that of 
STEMI is arterial occlusion due to acute thrombus formation 
(2). Similar in-hospital mortality has been reported for STEMI 
versus NSTEMI, but most studies have described STEMI as 
more severe due to differences in pathophysiology (3-5).
  There is no consensus as to which AMI subtype poses a 
greater risk after coronary artery bypass grafting (CABG). Pro-
pensity score matching analysis showed similar surgical out-
comes between subtypes, but no prediction of in-hospital mor-
tality or major adverse events after CABG (6). This study was 
subjected to patients underwent off-pump coronary artery by-
pass grafting (OPCAB) and there were few reports about OPCAB 
in STEMI and NSTEMI, even though OPCAB has shown better 
surgical results in several high-risk groups. We compared the 
early and long-term results in STEMI and NSTEMI after OPCAB.
MATERIALS AND METHODS
Patient selection
We analyzed data from 320 patients who underwent OPCAB 
within 4 weeks of MI between January 2001 and June 2010. Of 
these patients, 83 patients were assigned to the STEMI group 
(group I), and 237 patients were assigned to the NSTEMI group 
(group II). We were able to match 74 patients in each group 
successfully using propensity score-matching analysis.
Operative details
The operative technique and graft strategy were previously de-
scribed (7). OPCAB was performed through a full sternotomy 
incision with harvesting the left internal thoracic artery in a 
semi-skeletonized fashion. The radial artery was harvested from 
the non-dominant forearm using a harmonic scalpel (Ethicon 
Endosurgery Inc., Cincinnati, OH, USA). When necessary, the 
great saphenous vein, right internal thoracic artery, or right gas-
troepiploic artery were harvested. Heparin was injected at a dose 
of 1 mg/kg to achieve an activated clotting time of at least 350 sec 
prior to ligation of the distal internal thoracic artery. Target arter-Hong S, et al.  •  Results of STEMI versus NSTEMI after OPCAB
154   http://jkms.org http://dx.doi.org/10.3346/jkms.2012.27.2.153
ies were stabilized with Octopus tissue stabilizer (Medtronic, 
Minneapolis, MN, USA). During anastomosis, both a carbon 
dioxide blower and irrigation with warm saline were used to re-
move blood from sites of arteriotomy.
Statistical analysis
To compare preoperative characteristics, continuous variables 
were expressed as the mean ± standard deviation (SD), and 
categorical data were tabulated as frequencies and percentages. 
For continuous variables, data were compared using chi-square 
test or Student’s t test. All reported probability values were two-
sided. A P value < 0.05 was considered statistically significant. 
The effect of MI subtype on clinical outcomes after OPCAB was 
determined using logistic regression, and results are expressed 
as odds ratios (OR) with 95% confidence intervals (CI). Among 
risk factors, those with a P value ≤ 0.1 were selected for multi-
variate analyses. The multivariate model was constructed by 
the enter method.
  For secondary analysis, logistic regression was used to gener-
ate a model to calculate propensity scores. The reliability of the 
model was evaluated using the Hosmer and Lemeshow good-
ness-of-fit statistical and residual analyses. Each STEMI patient 
was matched with a NSTEMI patient using the closest propen-
sity score. Patients and operative variables were used to calcu-
late the propensity score. All data were analyzed using the SPSS 
software package for Windows (Statistical Product and Services 
Solutions, version 18.0, SPSS Inc., Chicago, IL, USA).
Ethics statement
This study was reviewed and approved by the institutional re-
view board of the of Yonsei University College of Medicine (4-
2010-0630). Informed consent was waived by the board.
RESULTS
Baseline characteristics
Preoperative characteristics are listed in Table 1. Before pro-
pensity score matching, group I had a higher EuroSCORE (P <
0.01) and a higher prevalence of emergency surgery (P < 0.01), 
preoperative intra-aortic balloon pump (IABP) use (P < 0.01), 
preoperative emergency percutaneous transluminal coronary 
angioplasty (PTCA; P < 0.01), and preoperative thrombolysis 
(P < 0.01). The STEMI group had a larger proportion of patients 
undergoing OPCAB within 1 day of the event. Operative char-
acteristics were similar between groups.
Hospital outcomes
In-hospital outcomes are listed in Table 2. There was no 30-day 
mortality in the STEMI group, but three patients had 30-day mor-
tality (1.3%) in the NSTEMI group (P = 0.57). The prevalence of 
renal failure, cerebrovascular accident, pneumonia, deep sternal 
wound infection, and 30-day major adverse cardiac and cere-
brovascular event (MACCE) were similar between groups. The 
Table 1. Preoperative and operative characteristics in STEMI and NSTEMI
Parameters
STEMI  
n = 83 (%)
NSTEMI  
n = 237 (%)
P value
Age (yr) 60.9 ± 9.39 64.0 ± 9.37 0.01
EuroSCORE 6.01 ± 1.55 5.43 ± 1.65 0.02
Ejection fraction (preoperative, %) 46.1 ± 12.3 48.1 ± 13.1 0.18
Female gender 20 (24.1) 62 (26.2) 0.77
Diabetes mellitus 39 (47.0) 117 (49.4) 0.79
Obesity (BMI > 25 kg/m
2) 29 (34.9) 89 (37.6) 0.69
Hypertension 49 (59.0) 140 (59.1) 0.99
Smoking 41 (49.4) 114 (48.1) 0.83
Dyslipidemia 50 (60.2) 120 (50.6) 0.13
End-stage renal disease 2 (2.4) 9 (3.8) 0.55
Cerebral vascular disease 4 (4.8) 8 (3.3) 0.67
Peripheral artery obstructive disease 12 (14.5) 35 (14.5) 0.94
Left main disease 30 (36.1) 91 (38.4) 0.71
Three vessel disease 76 (91.6) 227 (95.8) 0.25
Emergency 19 (22.9) 24 (10.1) < 0.01
Preoperative IABP  6 (7.2) 2 (0.8) < 0.01
Preoperative emergency PTCA 4 (4.8) 1 (0.4) < 0.01
Preoperative thrombolysis  12 (14.5) 4 (1.7) < 0.01
Time between MI and OPCAB
   < 1 day
   < 7 days
   < 15 days












Complete revascularization 77 (92.8) 206 (86.9) 0.21
Distal anastomosis 3.06 ± 0.68 3.14 ± 0.83 0.43
Used graft
   Both internal thoracic artery
   Radial artery 










Total arterial graft 48 (63.1) 151 (65.1) 0.20
Values are presented as the mean ± SD or number (%). BMI, body mass index;       
EuroSCORE, European system for cardiac operative risk evaluation; IABP, intra-aortic 
balloon pump; MI, myocardial infarction; NSTEMI, non-ST-segment elevation myocar-
dial infarction; OPCAB, off-pump coronary artery bypass surgery; PTCA, percutane-
ous transluminal coronary angioplasty; STEMI, ST-segment elevation myocardial in-
farction. 
Table 2. Early surgical results after OPCAB in STEMI and NSTEMI
Clinical outcomes
STEMI  
n = 83 (%)
NSTEMI  
n = 237 (%)
P value
30-day mortality 0 (0.0) 3 (1.3) 0.57
Renal failure (dialysis) 4 (4.8) 6 (2.5) 0.22
Cerebrovascular accident 1 (1.2) 4 (1.6) 0.92
Prolonged ventilation ( > 24 hr) 22 (26.5) 51 (21.5) 0.36
Postoperative pneumonia 0 (0.0) 7 (3.0) 0.19
Deep sternal wound infection 0 (0.0) 2 (0.8) 0.61
Postoperative ventricular arrhythmia 0 (0.0) 5 (2.1) 0.24
Perioperative myocardial infarction 
   (reinfarction)
2 (2.4) 7 (3.0) 1.00
30-day MACCE 4 (4.8) 20 (8.4) 0.12
Values are presented as the mean ± SD or number (%). MACCE, major adverse car-
diac and cerebrovascular event; NSTEMI, non-ST-segment elevation myocardial infarc-
tion; OPCAB, off-pump coronary artery bypass surgery; PTCA, percutaneous translu-
minal coronary angioplasty; STEMI, ST-segment elevation myocardial infarction.Hong S, et al.  •  Results of STEMI versus NSTEMI after OPCAB
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prevalence of prolonged ventilation ( > 24 hr) was higher in the 
STEMI group, but was not statistically significant. Stepwise regres-
sion analysis showed that low ejection fraction, chronic renal fail-
ure, and peripheral artery occlusive disease were independent 
risk factors for 30-day MACCE irrespective of MI type (Table 3).
Survival
Overall 8-yr survival was 93% and 87% in group I and II, respec-
tively (P = 0.07; Fig. 1A), and 8-yr MACCE-free survival was 
89.4% and 89.2% in groups I and II, respectively (P = 0.26; Fig. 
1B). Cox regression analysis revealed that low ejection fraction, 
chronic renal failure, and cerebrovascular accident were inde-
pendent risk factors in MACCE (Table 4), and low ejection frac-
tion, hypertension, and chronic renal failure were independent 
risk factors in overall survival (Table 5). Type of myocardial in-
farction was not an independent predictor of either MACCE or 
overall survival.
Table 3. Potential independent risk factors for 30-day major adverse cardiac and 
cerebrovascular events after OPCAB in patients with STEMI or NSTEMI
Risk factors OR 95% CI P value
Age (yr) 1.00 0.92-1.18 0.99
EuroSCORE 1.02 0.95-1.06 0.70
Ejection fraction (preoperative, %) < 35 3.02 1.04-8.72 0.04
Female gender 2.53 0.81-7.82 0.10
Diabetes mellitus 0.76 0.30-1.90 0.56
Obesity (BMI > 25 kg/m
2) 0.29 0.36-2.31 0.84
Hypertension 2.47 0.88-6.91 0.08
Type of myocardial infarction 0.37 0.09-1.42 0.15
NYHA > III 1.04 0.40-2.73 0.92
Smoking 1.32 0.46-3.83 0.83
Dyslipidemia 0.73 0.30-1.78 0.49
Chronic renal failure 6.41 2.11-19.4 0.001
Cerebrovascular accident 2.87 0.73-11.2 0.13
Peripheral artery obstructive disease 3.18 1.15-8.82 0.02
Left main disease 0.77 0.32-1.94 0.59
Three vessel disease 0.62 0.33-1.16 0.14
Emergency 2.15 0.53-8.62 0.27
Preoperative IABP  2.97 0.32-27.0 0.33
Preoperative thrombolysis  0.70 0.09-8.01 0.78
BMI, body mass index; CI, confidence interval; EuroSCORE, European System for 
Cardiac Operative Risk Evaluation; IABP, intra-aortic balloon pump; NSTEMI, non-ST-
segment elevation myocardial infarction; OPCAB, off-pump coronary artery bypass 
surgery; OR, odds ratio; PTCA, percutaneous transluminal coronary angioplasty; STE-
MI, ST-segment elevation myocardial infarction.
Fig. 1. Survival curves after OPCAB in STEMI and NSTEMI. (A) Overall survival after OPCAB in STEMI and NSTEMI. Overall 8-yr survival was 93% and 87% in groups I and II, 
respectively (P = 0.07). (B) MACCE-free survival after OPCAB in STEMI and NSTEMI. Eight-year MACCE-free survival was 89.4% and 89.2% in groups I and II, respectively (P = 
0.26). (C) Overall survival after OPCAB in STEMI and NSTEMI after propensity matching analysis. Overall 8-yr survival was 97% in each group after propensity score matching (P = 
0.53). OPCAB, off-pump coronary artery bypass grafting surgery; STEMI, ST elevation myocardial infarction; NSTEMI, non-ST elevation myocardial infarction; MACCE, major 
cardiovascular and cerebrovascular event; BMI, body mass index; CABG, coronary artery bypass grafting; CI, confidence interval; CPB, cardiopulmonary bypass; EuroSCORE, 
European System for Cardiac Operative Risk Evaluation; IABP, intra-aortic balloon pump; AMI, acute myocardial infarction; OR, odds ratio; PTCA, percutaneous transluminal cor-
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Table 4. Potential independent risk factors for major adverse cardiac and cerebro-
vascular events after OPCAB in patients with STEMI or NSTEMI
Risk factors OR 95% CI P value
Age (yr) 1.03 0.97-1.09 0.22
EuroSCORE 0.96 0.71-1.31 0.82
Ejection fraction (preoperative, %) < 35 3.44 1.25-9.48 0.01
Female gender 1.27 0.36-4.47 0.70
Diabetes mellitus 1.09 0.38-3.10 0.87
Obesity (BMI > 25 kg/m
2) 0.56 0.11-2.80 0.48
Hypertension 1.96 0.70-5.50 0.19
Type of myocardial infarction 0.64 0.19-2.14 0.47
NYHA > III 1.66 0.55-5.00 0.36
Smoking 1.60 0.54-4.71 0.39
Dyslipidemia 0.37 0.70-5.50 0.06
Chronic renal failure 4.63 1.44-14.8 0.01
Cerebrovascular accident 4.18 1.21-14.4 0.02
Peripheral artery obstructive disease 1.92 0.70-5.23 0.19
Left main disease 0.69 0.25-1.89 0.48
Three vessel disease 0.50 0.05-4.60 0.54
Emergency 2.06 0.62-6.84 0.23
Preoperative IABP use 1.83 0.16-20.6 0.62
Preoperative thrombolysis  0.93 0.10-8.24 0.95
BMI, body mass index; CI, confidence interval; EuroSCORE, European System for Car-
diac Operative Risk Evaluation; NSTEMI, non-ST-segment elevation myocardial infarc-
tion; NYHA, New York Heart Association; OPCAB, off-pump coronary artery bypass 
surgery; OR, odds ratio; STEMI, ST-segment elevation myocardial infarction.Hong S, et al.  •  Results of STEMI versus NSTEMI after OPCAB
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Propensity score matching
To account for potential confounding factors and case selection 
biases, a secondary analysis was performed using propensity 
score matching. In the matched analysis, 74 pairs of patients 
(matching rate, 89.2%) were selected. The previously described 
differences in baseline characteristics between unmatched 
groups were eliminated after matching (Table 6). Incidences of 
30-day mortality, renal failure, cerebrovascular accident, and 
30-day MACCE were similar between matched groups (Table 
7). Overall 8-yr survival was 97% in each group after matching 
(P = 0.53; Fig. 1C).
DISCUSSION
STEMI is commonly the consequence of the complete occlu-
sion of the culprit artery with a fibrin-rich thrombus, while 
NSTEMI is caused by transient coronary occlusion with a plate-
let-rich thrombus (8). As a result of these pathophysiological 
differences, STEMI generally results in a larger infarction than 
NSTEMI (9). As a result of non-surgical treatments in STEMI 
and NSTEMI patients, STEMI patients usually experience worse 
clinical outcomes (10-12). The preoperative characteristics of 
our study reveal the prevalence of surgical emergency, preop-
erative IABP use, preoperative emergent PTCA, and preopera-
tive thrombolysis were higher in STEMI patients. These find-
ings indicate the unstable hemodynamic status of the preoper-
ative period due to pathophysiological differences between 
STEMI and NSTEMI patients.
  There have been a few reports related to surgical results ac-
cording to the type of myocardial infarction (MI) and the timing 
of CABG. In a previous study, the in-hospital mortality of pa-
tients with Q-wave MI who underwent CABG between 6 and 23 
hr after the event was double that of the non-Q-wave MI pa-
tients (13). When the timing of surgery after MI was between 2 
and 42 days, mortality of Q-wave MI patients was still higher 
than that of non-Q-wave MI patients (14). In contrast, other 
studies showed similar mortality rates after surgical revascular-
ization. Both STEMI and NSTEMI patients had comparable mor-
tality rates after surgery within 24 hr of MI, and the preoperative 
characteristics were also similar between the groups (15). Re-




n = 74 (%)
NSTEMI  
n = 74 (%)
P value
Age (yr) 60.5 ± 9.30 60.1 ± 8.85 0.78
EuroSCORE 5.58 ± 1.65 5.46 ± 1.25 0.61
Ejection fraction (preoperative, %) 46.2 ± 12.8 46.0 ± 13.4 0.90
Female gender 18 (24.3) 18 (24.3) 1.00
Diabetes mellitus 33 (44.6) 33 (44.6) 1.00
Obesity (BMI > 25 kg/m
2) 27 (36.5) 25 (33.8) 0.86
Hypertension 42 (56.8) 41 (55.4) 0.91
Smoking 37 (50.0) 35 (47.3) 0.87
Dyslipidemia 42 (56.8) 41 (55.4) 1.00
End-stage renal disease 2 (2.7) 0 (0.0) 0.49
Cerebrovascular accident 0 (0.0) 0 (0.0)
Peripheral artery obstructive disease 12 (16.2) 11 (14.9) 1.00
Left main disease 28 (37.8) 28 (37.8) 1.00
Three vessel disease 72 (97.3) 70 (94.6) 0.68
Emergency 16 (21.6) 13 (17.6) 0.67
Preoperative IABP  6 (7.2) 2 (2.7) 0.27
Preoperative emergency PTCA 3 (4.1) 1 (1.4) 0.44
Preoperative thrombolysis  10 (13.5) 4 (5.4) 0.07
Values are presented as the mean ± SD or number (%). BMI, body mass index; Eu-
roSCORE, European System for Cardiac Operative Risk Evaluation; IABP, intra-aortic 
balloon pump; NSTEMI, non-ST-segment elevation myocardial infarction; PTCA, per-
cutaneous transluminal coronary angioplasty; STEMI, ST-segment elevation myocar-
dial infarction.




n = 74 (%)
NSTEMI  
n = 74 (%)
P value
30-day mortality 0 (0) 0 (0)
Renal failure (dialysis) 1 (1.4) 2 (2.7) 0.56
Cerebrovascular accident 1 (1.4) 2 (2.7) 0.56
Prolonged ventilation ( > 24 h) 19 (25.7) 18 (24.3) 0.84
Postoperative pneumonia 0 (0.0) 1 (1.4) 0.31
Deep sternal wound infection 0 (0) 0 (0)
Postoperative ventricular arrhythmia 0 (0.0) 2 (2.7) 0.47
Perioperative myocardial infarction
   (reinfarction)
1 (1.4) 2 (2.7) 0.56
30-day MACCE 2 (2.7) 2 (2.7) 1.00
MACCE, major cardiovascular and cerebrovascular event; NSTEMI, non-ST-segment 
elevation myocardial infarction; OPCAB, off-pump coronary artery bypass surgery; 
STEMI, ST-segment elevation myocardial infarction.
Table 5. Potential independent risk factors for overall survival after OPCAB in patients 
with STEMI or NSTEMI
Risk factors OR 95% CI P value
Age (yr) 1.06 0.96-1.16 0.21
EuroSCORE 1.08 0.74-1.55 0.68
Ejection fraction (preoperative, %) < 35 6.70 1.59-28.1 0.009
Female gender 1.32 0.27-6.50 0.72
Diabetes mellitus 2.19 0.52-9.23 0.28
Obesity (BMI > 25 kg/m
2) 1.12 0.16-7.80 0.90
Hypertension 4.85 0.90-25.1 0.05
Type of myocardial infarction 0.11 0.01-1.30 0.09
NYHA > III 1.10 0.31-3.88 0.87
Smoking 0.90 0.17-4.55 0.90
Dyslipidemia 0.35 0.48-7.33 0.35
Chronic renal failure 13.9 3.13-62.2 0.001
Cerebrovascular accident 0.55 0.07-4.18 0.57
Peripheral artery obstructive disease 0.75 0.14-4.02 0.74
Left main disease 0.79 0.22-3.18 0.79
Three vessel disease 0.50 0.05-4.60 0.54
Emergency 4.45 0.73-26.9 0.10
Preoperative thrombolysis  2.27 0.15-33.8 0.55
BMI, body mass index; CI, confidence interval; EuroSCORE, European System for Car-
diac Operative Risk Evaluation; NSTEMI, non-ST-segment elevation myocardial infarc-
tion; NYHA, New York Heart Association; OPCAB, off-pump coronary artery bypass 
surgery; OR, odds ratio; STEMI, ST-segment elevation myocardial infarction.Hong S, et al.  •  Results of STEMI versus NSTEMI after OPCAB
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cently, Zhang and colleagues studied 2,400 patients who un-
derwent isolated CABG within 21 days after MI, finding that MI 
subtype did not predict in-hospital mortality or major adverse 
events (6). However, most previous studies have focused on the 
surgical results of CABG using cardiopulmonary bypass (CPB), 
but few have compared the results of OPCAB in STEMI and 
NSTEMI. In our study, all surgical treatments were performed 
without CPB; although the EuroSCOREs were higher and pre-
operative hemodynamic status was more unstable in the STE-
MI group, the postoperative results were similar between groups 
after OPCAB.
  We performed secondary analysis using propensity score 
matching to eliminate these previously described differences in 
baseline characteristics. We found no significant differences in 
postoperative clinical outcomes or long-term survival between 
matched groups. Our results also showed similar results be-
tween the groups, irrespective of MI type and timing of CABG, 
although group I had adverse preoperative conditions, which 
might be lessened using OPCAB.
  Why were the surgical results of OPCAB similar despite dif-
ferences in preoperative clinical conditions? We think OPCAB 
has several advantages compared to CABG.
  Puskas et al. (16) reported that OPCAB was associated with 
lower operative mortality than CABG on CPB for high-risk pa-
tients, and this mortality benefit increased with increasing risk 
factors. In our study, we think similar results between the 
groups were also because of OPCAB.
  In terms of the timing of surgical management after AMI, 
early surgical revascularization has the advantage of limiting 
infarct expansion and adverse ventricular remodeling but has 
substantial risks of systemic inflammatory response and reper-
fusion injury, which might lead to hemorrhagic infarct exten-
sion and result in more extensive myocardial injury (17, 18). It 
has been reported that mortality was more than double base-
line values when surgery is performed within 3 days of trans-
mural AMI (19). The reason is unclear, but it may be that C-re-
active protein, a marker of acute inflammatory response that 
increases precipitously after transmural AMI and is a strong in-
dicator of prognosis, plateaus on day 3 after MI (20-22). Hagl et 
al. (23) analyzed retrospectively patients with STEMI who under-
went CABG in the first 48 hr after the onset of symptoms. Thirty-
day mortality was 20% in the entire group and 30% in the group 
with cardiogenic shock. If we consider that 33% of patients ex-
hibit cardiogenic shock in this study, emergency CABG in pa-
tients with MI could be performed with acceptable results, es-
pecially in those without cardiogenic shock. In our study, group 
I had a larger proportion of patients who underwent OPCAB 
within 1 day of the event. However, there was no 30-day mortal-
ity among patients with STEMI who underwent OPCAB. It may 
be difficult to compare our results with those of previous stud-
ies because surgical revascularization in previous studies was 
performed using CPB. During CPB, the heart is subjected to 
chemical cytotoxins, activated neutrophils, and regional hypo-
perfusion (24). Additionally, distension of the flaccid heart dur-
ing aortic cross-clamping reduces myocardial contractility (25). 
This decreased contractility increases ventricular end diastolic 
volume, myocardial wall stress, and oxygen consumption during 
weaning from CPB (24). These factors, coupled with reperfusion 
injury, could result in postoperative myocardial dysfunction. 
The incidence of postoperative MI is comparable after OPCAB 
and CABG with CPB, but OPCAB is associated with a more rap-
id recovery of myocardial oxidative metabolism, better myocar-
dial function, and a lower requirement for inotropic agents (26, 
27). In transcriptomic analyses of left ventricular biopsies ob-
tained from patients both prior to and after completion of all 
coronary anastomoses between OPCAB and on-pump surgery, 
inflammatory genes were upregulated more than 2-fold in the 
on-pump group after surgery. In addition, on-pump surgery in-
duced injury-related responses, as demonstrated by the upreg-
ulation of apoptosis and remodeling markers, whereas off-pump 
surgery ameliorated these responses by upregulating a cyto-
protective genetic program (28). This study showed a mecha-
nistic explanation for the reduction in the myocardial injury   
after OPCAB. Considering these advantages of OPCAB in myo-
cardial protection, OPCAB, although performed early after MI, 
could decrease postoperative myocardial dysfunction. There-
fore, in our study, although a larger proportion of patients un-
derwent OPCAB within 1 day of the event (group I), early surgi-
cal revascularization did not increase 30-day mortality.
  Our study has several limitations. The first is the retrospective 
nature of this study. To minimize this concern, we performed 
secondary analysis using propensity score matching. Second, 
OPCAB was performed by several surgeons at a single institu-
tion. Third, PTCA was usually tried as a first-time treatment in 
patients with STEMI, so patients with STEMI in this study might 
have a higher risk of preoperative characteristics than patients 
with NSTEMI. Fourth, our study showed the superior result of 
OPCAB in patients with AMI irrespective of MI type, but this 
was not the results derived from comparing OPCAB and con-
ventional CABG.
  In conclusion, the hemodynamic status of patients with STE-
MI was more unstable in the preoperative period, but there were 
no significant differences in clinical outcomes after OPCAB be-
tween STEMI and NSTEMI groups. The surgical results after 
OPCAB in patients with AMI are acceptable, even though OP-
CAB is performed early after MI. OPCAB therefore can be con-
sidered a treatment modality in patients with AMI regardless of 
MI type and timing.
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